HCPCS Code C9072

Injection, immune globulin (asceniv), 500 mg
Code effective Apr 01, 2021

HCPCS Section
Temporary Codes for Use with Outpatient Prospective Payment System

C9072 is a valid 2026 HCPCS code meaning Injection, immune globulin (asceniv), 500 mg or (Inj, imm glob asceniv) for short. HCPCS C9072 has been effective since 04/01/2021 and applies to Other medical items or services.

HCPCS Code Details - C9072

HCPCS Level II Code
Section C - Temporary Codes for Use with Outpatient Prospective Payment System
HCPCS Code C9072
Description

Long description:
Injection, immune globulin (asceniv), 500 mg

Short description:
Inj, imm glob asceniv

HCPCS Pricing indicator 53 - Statute
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Statute number 1833(T)
Coverage code D - Special coverage instructions apply
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 9 - Other medical items or services
Effective date Effective Apr 01, 2021
Date added Added Jan 01, 2021
Termination date Mar 31, 2021

See also

  • HCPCS C9071 · Injection, viltolarsen, 10 mg

  • HCPCS J1459 · Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg

  • HCPCS J1551 · Injection, immune globulin (cutaquig), 100 mg

  • HCPCS J1552 · Injection, immune globulin (alyglo), 500 mg

  • HCPCS J1553 · Injection, immune globulin (yimmugo), 100 mg

  • HCPCS J1554 · Injection, immune globulin (asceniv), 500 mg

  • HCPCS J1555 · Injection, immune globulin (cuvitru), 100 mg

  • HCPCS J1556 · Injection, immune globulin (bivigam), 500 mg

  • HCPCS J1557 · Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg

  • HCPCS J1558 · Injection, immune globulin (xembify), 100 mg

  • HCPCS J1559 · Injection, immune globulin (hizentra), 100 mg

  • HCPCS J1561 · Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg

  • HCPCS J1562 · Injection, immune globulin (vivaglobin), 100 mg

  • HCPCS J1566 · Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg

  • HCPCS J1568 · Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg

  • HCPCS J1569 · Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg

  • HCPCS C9073 · Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.